The angiotensin II type 2 receptor in renal disease
Suppression of angiotensin II formation by angiotensin-converting enzyme inhibitors or blockade of the angiotensin II receptor by angiotensin receptor blockers is a powerful therapeutic strategy to slow the progression of renal disease. However, angiotensin-converting enzyme inhibitors and angiotens...
Main Authors: | Ulrich Otto Wenzel, Christian Krebs, Ralf Benndorf |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2010-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320309347787 |
Similar Items
-
Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors
by: Hajaralsadat Hosseini-Dastgerdi, et al.
Published: (2022-01-01) -
The angiotensin II type 2 receptor in cardiovascular disease
by: Catherine A Lemarié, et al.
Published: (2010-03-01) -
Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
by: Ye-Ping Ma, et al.
Published: (2020-05-01) -
The angiotensin II type 2 receptor and the kidney
by: Helmy M Siragy
Published: (2010-03-01) -
The angiotensin II type 2 receptor in the brain
by: Masatsugu Horiuchi, et al.
Published: (2010-03-01)